InsideEdge
Live · scanner
All candidates

KLRS

NasdaqGMHealthcare
Kalaris Therapeutics, Inc.
Latest filing · 2026-05-20 · scanner 6d behind
$5.25
+6.7%· 24h
Score
50
/ 100
Active candidate
5 triggers firing
Large buyFirst buy 12moNet buying 90dSmall floatDays to cover
Market cap
$124.20M
Float
6.6M
28% of total
Shares out
23,792,278
Short % float
••••
Pro only
Days to cover
••••
Pro only
Price
KLRS
$5.25
$5.52 · -51.3%
3M
Insider buy · 2026-05-20 · $4.83 · AKKARAJU SRINIVAS
AI briefPro — synthesised analysis of insider signals and filing context.
Upgrade →
Rule breakdown50 / 110 pts max
45% of maximum scoreSignalContext
Form 4 signals
Cluster buy
3+ distinct insiders with open-market buys in the last 30 days
–
pts
C-suite buy
CEO, CFO, Chair, or President made an open-market purchase
–
pts
Large single buy
One open-market purchase exceeded the dollar threshold
$1,179,969
+15
pts
First buy in 12 months
An insider bought for the first time in the trailing 12 months
AKKARAJU SRINIVAS
+15
pts
Net buying (90d)
Net (buys − sells) USD over the last 90 days is positive
$1,179,969
+10
pts
Context amplifiers
High short interest
Short interest as % of float exceeds the squeeze threshold
–
pts
Small float
Float is below the threshold — amplifies any accumulation signal
6.6M shares
+5
pts
High days-to-cover
DTC > threshold — shorts can't exit cleanly on a squeeze
9.2d to cover
+5
pts
Volume spike
Most-recent day's volume was >2× the 20-day average
–
pts
TypeDateInsiderTitleSharesPriceValue
Buy2026-05-20
AKKARAJU SRINIVAS
244,300$4.83$1.18M
Other2026-05-20
AKKARAJU SRINIVAS
66,906$0.0000$0.0000
Other2026-05-20
AKKARAJU SRINIVAS
14,937$0.0000$0.0000
Other2026-05-20
AKKARAJU SRINIVAS
4,471$0.0000$0.0000